Medicure MCUJF
OTC MCUJF
$1.97 +0.02 (+1.03%)
At close: Sep 29, 2026 · 4:00 PM EDT

Medicure (MCUJF) Return on Assets [ROA] (2009 - 2026)

Updated

Medicure (MCUJF) posted Return on Assets [ROA] of -30.70% for the quarter ended Jun 30, 2026, down 22.41 percentage points from -8.29% a year earlier but up 1.64 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Medicure's Return on Assets [ROA] came in at -25.70%, down 22.12 percentage points from the prior year.

  • Annual Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -5.68 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Medicure's Return on Assets [ROA] was -3.57% in the year ended Dec 31, 2024 (-0.45 pp), -3.12% in the year ended Dec 31, 2023 (-7.72 pp), 4.60% in the year ended Dec 31, 2022 (+7.01 pp) and -2.41% in the year ended Dec 31, 2021 (+17.61 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -32.34% in the quarter ended Mar 31, 2026 to a high of 7.68% in the quarter ended Sep 30, 2022 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last six quarters, with an average year-over-year change of -14.09 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was the quarter ended Sep 30, 2022, with a gain of 23.57 percentage points; the weakest was the quarter ended Dec 31, 2025, with a drop of 30.32 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -32.34% (quarter ended Mar 31, 2026), -31.38% (quarter ended Dec 31, 2025) and -16.15% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Medicure 205.60 Mn 197.40 Mn 2.31 Mn -30.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.70%
Mar 31, 2026 -32.34%
Dec 31, 2025 -31.38%
Sep 30, 2025 -16.15%
Jun 30, 2025 -8.29%
Mar 31, 2025 -5.40%
Dec 31, 2024 -1.06%
Sep 30, 2024 -4.65%
Jun 30, 2024 -5.07%
Mar 31, 2024 -0.66%
Dec 31, 2023 -1.58%
Mar 31, 2023 0.63%
Dec 31, 2022 0.75%
Sep 30, 2022 7.68%
Jun 30, 2022 -1.62%
Mar 31, 2022 -1.87%
Dec 31, 2021 -7.22%
Sep 30, 2021 -15.89%
Jun 30, 2021 -13.91%
Mar 31, 2021 -15.56%
API Access

Medicure Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MCUJF&period=max&api_key=YOUR_API_KEY